These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16098001)

  • 21. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
    Gisbert JP; Pérez-Aisa A; Castro-Fernández M; Barrio J; Rodrigo L; Cosme A; Gisbert JL; Marcos S; Moreno-Otero R
    Dig Liver Dis; 2010 Apr; 42(4):287-90. PubMed ID: 19632166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
    Michopoulos S; Tsibouris P; Bouzakis H; Balta A; Vougadiotis J; Broutet N; Kralios N
    Aliment Pharmacol Ther; 2000 Jun; 14(6):737-44. PubMed ID: 10848657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
    Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori.
    Savarino V; Zentilin P; Bisso G; Pivari M; Mele MR; Mela GS; Mansi C; Vigneri S; Termini R; Celle G
    Aliment Pharmacol Ther; 1999 May; 13(5):643-9. PubMed ID: 10233188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
    Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
    De Francesco V; Della Valle N; Stoppino V; Amoruso A; Muscatiello N; Panella C; Ierardi E
    Aliment Pharmacol Ther; 2004 May; 19(9):993-8. PubMed ID: 15113366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
    Savarino V; Zentilin P; Bisso G; Pivari M; Bilardi C; Biagini R; Mele MR; Mansi C; Termini R; Vigneri S; Celle G
    Aliment Pharmacol Ther; 1999 Jan; 13(1):43-7. PubMed ID: 9892878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
    Savarino V; Zentilin P; Pivari M; Bisso G; Raffaella Mele M; Bilardi C; Borro P; Dulbecco P; Tessieri L; Mansi C; Borgonovo G; De Salvo L; Vigneri S
    Aliment Pharmacol Ther; 2000 Jul; 14(7):893-900. PubMed ID: 10886045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.
    Miehlke S; Schneider-Brachert W; Bästlein E; Ebert S; Kirsch C; Haferland C; Buchner M; Neumeyer M; Vieth M; Stolte M; Lehn N; Bayerdörffer E
    Aliment Pharmacol Ther; 2003 Oct; 18(8):799-804. PubMed ID: 14535873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Four different treatment protocols for Helicobacter pylori infection--a clinical pilot study].
    Cavaljuga S; Gornjaković S; Potkonjak D
    Med Arh; 2003; 57(3):151-6. PubMed ID: 12858654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: an overview.
    Ciociola AA; Webb DD; Turner K
    Scand J Gastroenterol Suppl; 1996; 218():3-9. PubMed ID: 8865444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ranitidine and lansoprazole in short-term low-dose triple therapy for Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Taniguchi Y; Takimoto T; Yamamoto H; Ido K; Yoshida Y; Kimura K
    Aliment Pharmacol Ther; 1997 Jun; 11(3):511-4. PubMed ID: 9218074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
    Castellote J; Porta F
    Med Clin (Barc); 2000 Jun; 115(3):118-9. PubMed ID: 10965489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.